ACADIA Pharmaceuticals (ACAD)

Create an Alert
18.29 -0.14  -0.76%   NASDAQ Jun 19, 12:24PM BATS Real time Currency in USD

ACADIA Pharmaceuticals Revenue Quarterly:

0.417M for March 31, 2013
View Full Chart

ACADIA Pharmaceuticals Revenue Quarterly Chart

    ACADIA Pharmaceuticals Historical Revenue Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 0.417M
    Dec. 31, 2012 0.38M
    Sept. 30, 2012 3.478M
    June 30, 2012 0.599M
    March 31, 2012 0.45M
    Dec. 31, 2011 0.588M
    Sept. 30, 2011 0.584M
    June 30, 2011 0.46M
    March 31, 2011 0.435M
    Dec. 31, 2010 35.40M
    Sept. 30, 2010 2.301M
    June 30, 2010 2.297M
    March 31, 2010 2.133M
    Dec. 31, 2009 1.769M
    Sept. 30, 2009 2.435M
    June 30, 2009 1.82M
    March 31, 2009 0.374M
    Dec. 31, 2008 0.325M
    Sept. 30, 2008 0.282M
    June 30, 2008 0.177M
    March 31, 2008 Go Pro
       
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro

    About Revenues

    Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity. Increasing revenues over time are generally a good sign of company's growth.

    While a bit obvious, if a lemonade company has sold 30 million in revenue and has 10 million in costs of goods sold, the company's revenue is still 30 million. (Expenses are not accounted in Revenue).
    Learn More

    Get data for

    ACAD Revenue Quarterly Benchmarks

    Companies
    MannKind Corporation 0.00
    Allergan 1.460B
    Insmed 0.00

    ACAD Revenue Quarterly Rankings

    Overall 54th percentile
    7575 of 16782
    Sector 51st percentile
    686 of 1410 in Healthcare
    Industry 60th percentile
    178 of 454 in Biotechnology

    ACAD Revenue Quarterly Range, Past 5 Years

    Minimum 0.1770M Jun 2008
    Maximum 35.40M Dec 2010
    Average 2.835M

    Access watchlists and custom data alerts.
    Start your free account.

    Registering enables you to view unlimited pages per month.

    required
    required
    required
    required
    Get Started Now

    Already registered? Sign in here.

    document.write('');